Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$121.17 - $128.59 $145,404 - $154,308
-1,200 Reduced 25.98%
3,419 $422,000
Q3 2023

Nov 14, 2023

BUY
$112.47 - $132.89 $224,940 - $265,780
2,000 Added 76.37%
4,619 $577,000
Q2 2023

Aug 14, 2023

BUY
$112.49 - $121.7 $24,635 - $26,652
219 Added 9.13%
2,619 $303,000
Q1 2023

May 15, 2023

BUY
$109.21 - $120.25 $262,103 - $288,600
2,400 New
2,400 $283,000
Q3 2018

Nov 14, 2018

SELL
$93.29 - $111.97 $229,400 - $275,334
-2,459 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$87.93 - $96.13 $400,960 - $438,352
-4,560 Reduced 64.97%
2,459 $230,000
Q1 2018

May 15, 2018

BUY
$81.38 - $91.83 $571,206 - $644,554
7,019 New
7,019 $631,000

Others Institutions Holding ATR

About APTARGROUP, INC.


  • Ticker ATR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 65,337,000
  • Market Cap $11.3B
  • Description
  • AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps...
More about ATR
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.